e 4031 has been researched along with Adverse Drug Event in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bussek, A | 1 |
| Schmidt, M | 1 |
| Bauriedl, J | 1 |
| Ravens, U | 1 |
| Wettwer, E | 1 |
| Lohmann, H | 1 |
1 other study available for e 4031 and Adverse Drug Event
| Article | Year |
|---|---|
Cardiac tissue slices with prolonged survival for in vitro drug safety screening.
Topics: 4-Aminopyridine; Action Potentials; Animal Testing Alternatives; Animals; Animals, Laboratory; Anti- | 2012 |